SATURDAY, APRIL 12, 2025

COVID-19 Therapies: What Pharmacists Need to Know  

 8:00-9:30am C/G/T

Kathleen Jodoin, PharmD, BCPS, Pharmacy Clinical Coordinator, Mount Sinai Medical Center

Upon completion of this activity, pharmacists will be able to: Describe the pathophysiology of COVID-19; Review current guidelines and recommendations for COVID-19 management; Assess the role of pharmacists in COVID-19 prevention and management; Provide an overview of recent clinical studies, including emerging therapies for COVID-19 management. 

UAN: 0675-0000-25-011-L01-P*

Upon completion of this activity, technicians will be able to: Describe the progression of COVID-19; Review current guidelines and recommendations for COVID-19 management; Provide an overview of recent clinical studies, including emerging therapies for COVID-19 treatment.  

UAN: 0675-0000-25-011-L01-T* 

Navigating Clinical Guidelines: Best Practices for the Management of Pneumonia

9:30-11:00am C/G/T

Marylee Tailor, PharmD, BCIDP, Clinical Pharmacist

Upon completion of this activity, pharmacists will be able to:  Identify new updates in the management of pneumonia; Interpret the utilization of biomarkers and their potential use in patients with pneumonia; Describe the strengths and limitations of new antimicrobials to treat patients with pneumonia; Select patient-specific antimicrobial therapy for the treatment of pneumonia based on clinical practice guidelines.. 

UAN: 0675-0000-25-012-L01-P*

Upon completion of this activity, technicians will be able to: Identify new updates in the management of pneumonia; Interpret the utilization of biomarkers and their potential use in patients with pneumonia; Describe the strengths and limitations of new antimicrobials to treat patients with pneumonia.   

UAN: 0675-0000-25-012-L01-T*

Herd It All Before: The Importance of Immunizations to Public Health

11:15-12:45pm C/G/T

Calvin Tucker, PharmD, MBA, FCCM, FFSHP, Manager, Cancer Center Pharmacy, Mayo Clinic 

Upon completion of this activity, pharmacists will be able to: Define the types of immunity; Explain the process of how immunizations are created; Describe the impact of immunizations on public health; Highlight the role of pharmacists in the vaccinations of patients.  

UAN: 0675-0000-25-013-L06-P

Upon completion of this activity, technicians will be able to: Define the types of immunity; Explain the process of how immunizations are created; Describe the impact of immunizations on public health.

UAN: 0675-0000-25-013-L06-T

Pharmacologic Strategies for CDI: from first -Line Therapy to Recurrent Infections

12:45-2:15pm C/G/T

Kathleen Jodoin, PharmD, BCPS, Pharmacy Clinical Coordinator, Mount Sinai Medical Center
Upon completion of this activity, pharmacists will be able to: Describe the pathophysiology of Clostridioides difficile infection (CDI); Review the evolution of CDI management guidelines; Review current guidelines and recommendations for CDI management; Assess management strategies for severe and recurrent CDI, including new therapies.

UAN: 0675-0000-25-014-L01-P

Upon completion of this activity, technicians will be able to: Define Clostridioides difficile infection (CDI); Review the evolution of CDI management guidelines; Review current guidelines and recommendations for CDI management.

UAN: 0675-0000-25-014-L01-T

C = Consultant CPE G = General Pharmacist CPE T = Technician CPE